Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure

Flagg ME, Bhandari SK, Pak KJ, Zhou H, Shaw SF, Shi JM, Rhee CM, Broder BI, Sim JJ. Dialysis Transition Patterns of Chronic Kidney Disease[...]

The history and future of online hemodiafiltration and online solutions in North America

Leduc C, Tomisawa N, Ronco C, Kalantar-Zadeh K. The history and future of online hemodiafiltration and online solutions in North America. Curr Opin Nephrol Hypertens.[...]

A New Quantitative Approach for Correcting Cirrhosis-Associated Hyponatremia by Inducing Negative Water Balance in Excess of Negative Sodium and Potassium Balance

Nguyen MK, Nguyen MK, Bandaru D. A New Quantitative Approach for Correcting Cirrhosis-Associated Hyponatremia by Inducing Negative Water Balance in Excess of Negative Sodium and[...]